Oxygen Biotherapeutics, Inc. Provides A Business Review And Update In Conjunction With Filing Of Second Quarter Fiscal Year 2014 Financials

Oxygen Biotherapeutics, Inc.,(“OBI”) (NASDAQ: OXBT) a specialty pharmaceutical company focused on developing and commercializing a portfolio of products for the critical care market, today announced that it has filed its Quarterly Report on Form 10-Q for its second quarter fiscal year (FY) 2014 ended October 31, 2013. In connection with that filing, the company is providing a review of recent achievements and an update on business operations and future milestones.

Help employers find you! Check out all the jobs and post your resume.